Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 4 August 2008. doi:10.1136/jcp.2008.057950
Journal of Clinical Pathology 2008;61:1073-1082
Copyright © 2008 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

REVIEW

Hereditary breast cancer: from molecular pathology to tailored therapies

D S P Tan, C Marchiò, J S Reis-Filho

Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK

Dr J S Reis-Filho, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK; jorge.reis-filho{at}icr.ac.uk

Hereditary breast cancer accounts for up to 5–10% of all breast carcinomas. Recent studies have demonstrated that mutations in two high-penetrance genes, namely BRCA1 and BRCA2, are responsible for about 16% of the familial risk of breast cancer. Even though subsequent studies have failed to find another high-penetrance breast cancer susceptibility gene, several genes that confer a moderate to low risk of breast cancer development have been identified; moreover, hereditary breast cancer can be part of multiple cancer syndromes. In this review we will focus on the hereditary breast carcinomas caused by mutations in BRCA1, BRCA2, Fanconi anaemia (FANC) genes, CHK2 and ATM tumour suppressor genes. We describe the hallmark histological features of these carcinomas compared with non-hereditary breast cancers and show how an accurate histopathological diagnosis may help improve the identification of patients to be screened for mutations. Finally, novel therapeutic approaches to treat patients with BRCA1 and BRCA2 germ line mutations, including cross-linking agents and PARP inhibitors, are discussed.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Pasanisi, P., Hedelin, G., Berrino, J., Chang-Claude, J., Hermann, S., Steel, M., Haites, N., Hart, J., Peled, R., Gafa, L., Leggio, L., Traina, A., Amodio, R., Primic-Zakelj, M., Zadnik, V., Veidebaum, T., Tekkel, M., Berrino, F. (2009). Oral Contraceptive Use and BRCA Penetrance: A Case-Only Study. Cancer Epidemiol. Biomarkers Prev. 18: 2107-2113 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs